CBD, in contrast, is not known to produce any paranoia and anxiety People who suffer from impaired cognition due to fibromyalgia (called fibro fog) may not like the psychoactive effects of medical marijuana
Improved BMI, BFI, and waist-hip ratio without muscle loss*
Unexpected benefits for kidney and liver disease turned up in the diabetes trials, too
Anxiety during treatment has many possible causes, and several can be addressed without discontinuing the medication
Participants were 18 years and older and had type 2 diabetes with an HbA 1c of 7.0-10.5% on metformin therapy (n=1201)
The strategy of GLP-1RAs combined with non-pharmacological therapy for improving sarcopenia Given that the weight loss effect induced by GLP-1RAs is often accompanied by the risk of muscle loss, and this influence is regulated by multiple factors such as age, underlying diseases, and the duration of treatment, in order to retain muscle mass to the greatest extent, the clinical consensus suggests that GLP-1RA treatment must be combined with active non-pharmacological intervention